Cargando…

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature

Background and Objectives: Over the past twenty years a large number of new psychoactive substances (NPS) have entered and modified the recreational drug scene. Their intake has been associated with health-related risks, especially so for vulnerable populations such as people with severe mental illn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiappini, Stefania, Mosca, Alessio, Miuli, Andrea, Santovito, Maria Chiara, Orsolini, Laura, Corkery, John Martin, Guirguis, Amira, Pettorruso, Mauro, Martinotti, Giovanni, Di Giannantonio, Massimo, Schifano, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226910/ https://www.ncbi.nlm.nih.gov/pubmed/34204131 http://dx.doi.org/10.3390/medicina57060580

Ejemplares similares

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants
por: Schifano, Fabrizio, et al.
Publicado: (2021)

The Benzydamine Experience: A Systematic Review of Benzydamine Abuse
por: Stefania, Chiappini, et al.
Publicado: (2021)

Misuse of Anticholinergic Medications: A Systematic Review
por: Chiappini, Stefania, et al.
Publicado: (2022)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels’ Decline: A Narrative Review
por: Schifano, Nicolò, et al.
Publicado: (2022)

Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population
por: Chiappini, Stefania, et al.
Publicado: (2023)

Alprazolam-related deaths in Scotland, 2004–2020
por: Corkery, John Martin, et al.
Publicado: (2022)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
por: Catalani, Valeria, et al.
Publicado: (2021)

Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
por: Martinotti, Giovanni, et al.
Publicado: (2021)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
por: Chiappini, Stefania, et al.
Publicado: (2022)

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK
por: Gittins, Rosalind, et al.
Publicado: (2018)

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
por: Schifano, Fabrizio, et al.
Publicado: (2019)

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Schifano, Fabrizio, et al.
Publicado: (2019)

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
por: Chiappini, Stefania, et al.
Publicado: (2020)

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
por: Chiappini, Stefania, et al.
Publicado: (2021)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
por: Chiappini, Stefania, et al.
Publicado: (2022)

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances
por: Ramos, Camille, et al.
Publicado: (2020)

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?
por: Orsolini, Laura, et al.
Publicado: (2017)

From a Cycle to a Period: The Potential Role of BDNF as Plasticity and Phase-Specific Biomarker in Cocaine Use Disorder
por: Miuli, Andrea, et al.
Publicado: (2022)

COVID-19: The Hidden Impact on Mental Health and Drug Addiction
por: Chiappini, Stefania, et al.
Publicado: (2020)

‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports
por: Orsolini, Laura, et al.
Publicado: (2020)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
por: Chiappini, Stefania, et al.
Publicado: (2023)

Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis
por: Miuli, Andrea, et al.
Publicado: (2021)

Sexual Enhancement Products for Sale Online: Raising Awareness of the Psychoactive Effects of Yohimbine, Maca, Horny Goat Weed, and Ginkgo biloba
por: Corazza, Ornella, et al.
Publicado: (2014)

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
por: Arillotta, Davide, et al.
Publicado: (2021)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates
por: Pettorruso, Mauro, et al.
Publicado: (2020)

Suicidal Behavior and Club Drugs in Young Adults
por: Martinotti, Giovanni, et al.
Publicado: (2021)

Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History
por: Martinotti, Giovanni, et al.
Publicado: (2021)

Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis
por: Miuli, Andrea, et al.
Publicado: (2020)

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2017)

rTMS Reduces Psychopathological Burden and Cocaine Consumption in Treatment-Seeking Subjects With Cocaine Use Disorder: An Open Label, Feasibility Study
por: Pettorruso, Mauro, et al.
Publicado: (2019)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction
por: Chiappini, Stefania, et al.
Publicado: (2021)

Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II
por: Chiappini, Stefania, et al.
Publicado: (2022)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
por: Arillotta, Davide, et al.
Publicado: (2023)

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
por: Orsolini, Laura, et al.
Publicado: (2019)

Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions
por: d’Andrea, Giacomo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cu8hu4eul4egcj7ho2ica7068v